Skip to main content
Equibles
XAIR logo

XAIR · Beyond Air, Inc.

Track XAIR — free

Use XAIR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about XAIR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.32 -0.61 (-8.74%) At close · Aug 14
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management believes these factors raise substantial doubt about the Company’s ability to meet its obligations with cash on hand and concluded that the Company will require additional funding within one year from the date these financial statements are issued. Management is confident that the efforts to arrange financing, while not assured, will enable them to meet the Company’s obligations.”
View the 10-Q filed Aug 13, 2026
Market Cap
$6.05M
Shares
957,631

Beyond Air, Inc. Earnings Call Transcripts

Every quarterly earnings call for Beyond Air, Inc. (XAIR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $59,000 −$14.10M '24 Q1 23-08-15 · $239,000 −$16.22M '24 Q2 23-11-17 · $391,000 −$16.22M '24 Q3 24-02-16 · $470,000 −$13.71M '24 Q4 24-06-27 ▲1057.6% $683,000 −$12.20M '25 Q1 24-08-09 ▲233.9% $798,000 −$13.36M '25 Q2 24-11-18 ▲174.2% $1.07M −$13.03M '25 Q3 25-02-14 ▲145.1% $1.15M −$8.03M '25 Q4 25-06-18 ▲157.7% $1.76M −$7.69M '26 Q1 25-08-18 ▲127.8% $1.82M −$7.94M '26 Q2 25-11-14 ▲104.7% $2.19M −$7.34M '26 Q3 26-02-13 LATEST ▲65.5% $1.91M −$10.28M '26 Q4 26-06-26
Earnings call
FY26 · Q4
2026-06-26
Beyond Air, Inc. Q4 FY2026 Earnings Call
Confident tone Gen 2 LungFit PH FDA approval and launch Forward revenue guidance (CY2026 and CY2027) Revenue growth and commercial momentum
Revenue
$1.91M*
▲ 65.5% YoY
Gross margin
4.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-13
Beyond Air, Inc. Q3 FY2026 Earnings Call
Confident tone Gross margin profile LungFit PH commercial growth Second-generation LungFit PH system
Revenue
$2.19M
▲ 104.7% YoY
Diluted EPS
$-17.00
Gross margin
13.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-14
Beyond Air, Inc. Q2 FY2026 Earnings Call
Confident tone LungFit PH commercial adoption and revenue Balance sheet financing GPO contracts and hospital access
Revenue
$1.82M
▲ 127.8% YoY
Diluted EPS
$-25.00
Gross margin
-16.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-18
Beyond Air, Inc. Q1 FY2026 Earnings Call
Confident tone LungFit PH commercial momentum Hospital network and GPO access Revenue guidance and growth outlook
Revenue
$1.76M
▲ 157.7% YoY
Diluted EPS
$-30.67
Gross margin
8.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-06-18
Beyond Air, Inc. Q4 FY2025 Earnings Call
Confident tone LungFit PH U.S. commercial growth LungFit PH II / Gen 2 PMA supplement NeuroNOS autism / Alzheimer's pipeline
Revenue
$1.15M*
▲ 145.1% YoY
Gross margin
-2.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-14
Beyond Air, Inc. Q3 FY2025 Earnings Call
Confident tone LungFit PH system performance and customer feedback Cardiac surgery PMA supplement with FDA Beyond Cancer subsidiary UNO therapy Phase 1b
Revenue
$1.07M
▲ 174.2% YoY
Diluted EPS
$-59.20
Gross margin
-20.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-18
Beyond Air, Inc. Q2 FY2025 Earnings Call
Confident tone LungFit PH Commercial Momentum International Distribution Partnerships Next-Generation LungFit PH System
Revenue
$798,000
▲ 233.9% YoY
Diluted EPS
$-113.40
Gross margin
-135.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-08-09
Beyond Air, Inc. Q1 FY2025 Earnings Call
Revenue
$683,000
▲ 1057.6% YoY
Diluted EPS
$-106.40
Gross margin
-48.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-06-27
Beyond Air, Inc. Q4 FY2024 Earnings Call
Positive tone LungFit PH product and commercialization FDA PMA supplement for cardiac surgery label expansion New Chief Commercial Officer appointment
Revenue
$470,000*
Gross margin
-109.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-16
Beyond Air, Inc. Q3 FY2024 Earnings Call
Positive tone Vizient and GPO contracts Beyond Cancer UNO pipeline International expansion and CE Mark
Revenue
$391,000
Diluted EPS
$-200.00
Gross margin
-91.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-17
Beyond Air, Inc. Q2 FY2024 Earnings Call
Revenue
$239,000
Diluted EPS
$-204.00
Gross margin
-80.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-15
Beyond Air, Inc. Q1 FY2024 Earnings Call
Revenue
$59,000
Diluted EPS
$-180.00
Gross margin
-413.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-06-23
Beyond Air, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-13
Beyond Air, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-172.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Beyond Air, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-160.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-15
Beyond Air, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-148.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-30
Beyond Air, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Beyond Air, Inc. Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-15
Beyond Air, Inc. Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-11
Beyond Air, Inc. Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-16
Beyond Air, Inc. Q4 FY2021 Earnings Call
Revenue
$144,839*
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-11
Beyond Air, Inc. Q3 FY2021 Earnings Call
Revenue
$149,000
▼ 52.6% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-09-30
Beyond Air, Inc. Q2 FY2021 Earnings Call
Revenue
$350,000
▼ 45.8% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-08-12
Beyond Air, Inc. Q1 FY2021 Earnings Call
Revenue
$229,161
▼ 63.5% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-23
Beyond Air, Inc. Q4 FY2020 Earnings Call
Revenue
$*
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2019-09-30
Beyond Air, Inc. Q2 FY2020 Earnings Call
Revenue
$645,602
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 earnings calls
Key facts CIK 1641631 CUSIP 08862L301 13F (30d) 27 filings 26 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)